How many sites of action for endocannabinoids to control energy metabolism?
- 29 March 2006
- journal article
- review article
- Published by Springer Nature in International Journal of Obesity
- Vol. 30 (S1) , S39-S43
- https://doi.org/10.1038/sj.ijo.0803277
Abstract
The promising results obtained by clinical trials using Rimonabant to tackle visceral obesity and related disorders recently promoted a remarkable impulse to carry out detailed investigations into the mechanisms of action of endocannabinoids in regulating food intake and energy metabolism. The endocannabinoid system has been known for many years to play an important role in the modulation of the neuronal pathways mediating the rewarding properties of food. However, in the last few years, with the advanced understanding of the crucial role of the hypothalamic neuronal network in the regulation of appetite, several studies have also directed attention to the orexigenic role of the endocannabinoid system, substantiating the well known appetite stimulating properties of derivatives of Cannabis sativa. Furthermore, the last 2 years have seen a number of relevant publications emphasizing the role of endocannabinoids as significant players in various peripheral metabolic processes. To date, the roles of the endocannabinoid system in influencing energy metabolism have proved to be more complex than was formerly believed. However, the diverse ability to modulate both central and peripheral processes highlights the pivotal involvement of the endocannabinoid system in the control of metabolic processes. This review describes the roles of endocannabinoids and the cannabinoid type 1 receptor (CB1) in the control of energy balance.Keywords
This publication has 36 references indexed in Scilit:
- Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob miceInternational Journal of Obesity, 2004
- The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelinBritish Journal of Pharmacology, 2004
- Adiponectin, the missing link in insulin resistance and obesityClinical Nutrition, 2004
- Rapid Rewiring of Arcuate Nucleus Feeding Circuits by LeptinScience, 2004
- Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by CholecystokininJournal of Neuroscience, 2004
- Obesity Wars: Molecular Progress Confronts an Expanding EpidemicPublished by Elsevier ,2004
- Endogenous cannabinoid system as a modulator of food intakeInternational Journal of Obesity, 2003
- Anandamide administration into the ventromedial hypothalamus stimulates appetite in ratsBritish Journal of Pharmacology, 2001
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexiaJournal of Pain and Symptom Management, 1997